Position in INSM
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$12,775,208
-$5,384,996 QoQ
Shares Held
119,820
+7.9% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#148
of 663 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DANSKE BANK A/S holds $250,708,718 across 63 Biotechnology names. INSM ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
158,064 | $78,515,129 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
107,830 | $67,236,317 | |
| 3 | RPRX |
Royalty Pharma plc
|
766,678 | $42,987,635 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
64,555 | $19,432,990 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
79,200 | $14,832,576 | |
| 6 | INSM |
INSMED Inc
This page
|
119,820 | $12,775,208 | |
| 7 | INCY |
Incyte Corp
|
81,862 | $9,279,875 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
21,119 | $5,089,045 |
All Filings in INSM
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,775,208 | 119,820 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $18,160,204 | 111,058 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $19,189,302 | 110,258 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $345,624 | 2,400 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $241,536 | 2,400 | Shares | Sole | 2025-12-18 | |
| 2025-03-31 | $22,887 | 300 | Shares | Sole | 2025-12-18 | |
| 2024-12-31 | $20,712 | 300 | Shares | Sole | 2026-03-18 | |
| 2024-09-30 | $138,700 | 1,900 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $2,335,893 | 86,100 | Shares | Sole | 2026-03-18 | |
| No filing history on record for this holder in this stock. | ||||||